医学
吉西他滨
内科学
中性粒细胞减少症
临床终点
胰腺癌
胃肠病学
临床研究阶段
实体瘤疗效评价标准
恶心
贫血
肿瘤科
外科
癌症
化疗
临床试验
作者
Peter J. Hosein,Gilberto Lopes,Vitor H. Pastorini,C. Gomez,Jessica MacIntyre,Gloria Zayas,Isildinha M. Reis,Alberto J. Montero,Jaime R. Merchan,Caio M. Rocha Lima
标识
DOI:10.1097/coc.0b013e3182436e8c
摘要
nab-Paclitaxel was well tolerated, and it demonstrated preliminary evidence of activity in a subset of patients who progressed on gemcitabine-based therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI